Close Menu

In the Proceedings of the National Academy of Sciences this week, Yale University scientists have developed a cheap, microfluidic platform that uses biocompatible ferrofluids "for the controlled manipulation and rapid separation of both microparticles and live cells." Using microspheres, they achieved 99 percent separation efficiency based on size at less than 10-micron resolution, demonstrating the platform's potential in "significantly reducing incubation times and increasing diagnostic sensitivity in cellular assays

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.